Altimmune to participate in the citizens life sciences conference

Gaithersburg, md., april 30, 2025 (globe newswire) -- altimmune, inc. (nasdaq: alt), a late clinical-stage biopharmaceutical company, today announced that members of the company's management team will participate in a fireside chat at the citizens life sciences conference. details are as follows:

ALT Ratings Summary

ALT Quant Ranking